CHAMPION-AF: Left Atrial Appendage Closure vs. Anticoagulation For AFib

Device-based left atrial appendage (LAA) closure was comparable to non-vitamin K antagonist oral anticoagulant (NOAC) therapy in reducing the combined rate of death from cardiovascular causes, stroke, or systemic embolism at three years in…

Continue Reading


News Source: www.acc.org

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *